Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results

BACKGROUND: Tiotropium is a once-daily, long-acting anticholinergic bronchodilator with the potential to alleviate airway obstruction in cystic fibrosis. Our objective was to evaluate the efficacy and safety of 2.5 and 5 µg once-daily tiotropium delivered via the Respimat Soft Mist Inhaler vs. place...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Bradley, Judy M., Koker, Paul, Deng, Qiqi, Moroni-Zentgraf, Petra, Ratjen, Felix, Geller, David E., Elborn, J. Stuart
格式: Artigo
語言:Inglês
出版: Public Library of Science 2014
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4154718/
https://ncbi.nlm.nih.gov/pubmed/25188297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0106195
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍